Trial Profile
Depression and health outcomes in refractory epilepsy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Depression; Epilepsy; Major depressive disorder
- Focus Therapeutic Use
- 29 Jul 2019 Results published in the Annals of Neurology.
- 06 Nov 2017 Status changed from active, no longer recruiting to completed.
- 22 Apr 2009 Results reported at AAN 2009.